KALDVIK AS (KLDVK) reports Operating income in Q3 amounted to EURm 9.9 (EURm 24.5), while the operating loss before fair value adjustment of biomass and production tax was EURm -5.0 (EURm 2.1). Harvest amounted to 1.545 tonnes in Q3 2025 (3.798 tonnes) Kaldvík AS has revised its harvest guidance for the year 2025 down to 17.000 tonnes. Web cast will be at 09:00 (CET)/ 08:00 Icelandic time on 21 November 2025 on the following link: www.kaldvik.is/live Attached is the Company update for Q3 2025. Kaldvik, 21 November 2025 Contact: Robert Robertsson, CFO of KALDVIK AS: +354 843 0086 (mobile) This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.AttachmentKaldvik AS – Q3 2025 Company update

Dear shareholder, Dear Madam, Dear Sir,Ackermans & van Haaren has published its trading update for the third quarter of 2025:Excellent third quarter results of core participations AvH’s strong outlook for the full year 2025 confirmed Net cash position of 437 million eurosplease find attached our press release.Best regards Ackermans & van HaarenAttachmentAvH Trading Update 3Q2025: Excellent results of core participations, FY2025 outlook confirmed 20251120

Product Lineup Now Includes Bespoke Porsche 911 Builds and Modern Defender & INEOS Grenadier Enhancements KISSIMMEE, Fla., Nov. 20, 2025 (GLOBE NEWSWIRE) — ECD Automotive Design, Inc. (“ECD” or the “Company”) (NASDAQ: ECDA), the world’s largest Land Rover and Jaguar restoration company known for its custom luxury builds, including bespoke Defenders, Range Rovers, Jaguar E-Types, Ford Mustangs and Toyota FJs, announced today its financial results for the third quarter ended September 30, 2025. Management will host an earnings call and webcast on Monday, November 24, 2025 at 4:30 PM Eastern Time. Third Quarter HighlightsRevenue was $5.8 million in the third quarter of 2025, compared to $6.4 million in the third quarter of 2024. Gross loss was $1.7 million in the third quarter of 2025, compared to gross profit of $2.0 million...

MISSISSAUGA, Ontario, Nov. 20, 2025 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the three months (Q3) and nine months (YTD) ended September 30, 2025. Key highlights include:(CAD) Q3 2025 % Change vs.Q3 2024 YTD 2025 % Change vs.YTD 2024 Trailing Twelve Months (TTM) Sept 30, 2025 % Change vs.TTM Sept 30, 2024Canadian Pharma Sales 9,864,254 +19% 28,351,130 +16% 36,897,581 +14%International Pharma Sales 1,153,742 +94% 3,134,572 +316% 3,311,306 +310%Legacy Business Sales 1,203,808 +83% 1,894,358 +73% 1,967,857 +48%Total Company Sales 12,221,804 +28% 33,380,060 +27% 42,176,744 +22%EBITDA¹ 3,632,399 +27% 9,594,195 +35% 11,835,307 +35%Net Income After Taxes (NIAT) 2,682,340 +16% 7,020,444 +24% 8,633,638 +21%Fully Diluted EPS 0.23 +19% 0.61 +28% 0.75 +25%             Return...

– Q4 Sales increase 29% to $353 Million – Q4 Entered Orders increase 30% to $321 Million – Q4 GAAP EPS from Continuing Operations increases 14% to $1.73 – Q4 Adjusted EPS from Continuing Operations increases 30% to $2.32 – FY 2025 Sales increase 19% to $1.1 Billion – FY 2025 Entered Orders increase 57% to $1.6 Billion – FY 2025 GAAP EPS from Continuing Operations increases 13% to $4.49 – FY 2025 Adjusted EPS from Continuing Operations increases 26% to $6.03 – St. Louis, Nov. 20, 2025 (GLOBE NEWSWIRE) — ESCO Technologies Inc. (NYSE: ESE) (ESCO, or the Company) today reported its operating results for the fourth quarter and fiscal year ended September 30, 2025 (Q4 2025 and FY 2025, respectively). During Q4 2025, the Company completed the sale of VACCO Industries. The VACCO operating...

TRAVERSE CITY, Mich., Nov. 20, 2025 (GLOBE NEWSWIRE) — MachTen, Inc. (OTC: MACT) today announced financial results for the third quarter ended September 30, 2025. “Michigan Broadband delivered another quarter of disciplined execution, expanding our fiber footprint while continuing to invest in our teams, systems and capabilities that support scalable growth,” said Dan Miller, Chief Executive Officer. “We remain committed to building the most reliable network in every community we serve, driving long-term value for our customers, partners, and shareholders.” Third Quarter 2025 Financial HighlightsRevenue: $4.3 million was approximately flat compared to the third quarter of 2024, as new fiber-optic subscribers were offset by declines in copper-based voice and DSL customers. We expect revenue to improve in 2026 from an increase...

ST. LOUIS, Nov. 20, 2025 (GLOBE NEWSWIRE) — Stifel Financial Corp. (NYSE: SF) today reported selected operating results for October 31, 2025, to provide timely information to investors on certain key performance metrics. Due to the limited nature of this data, a consistent correlation to earnings should not be assumed. Ronald J. Kruszewski, Chairman and Chief Executive Officer, said, “Total client assets and fee-based client assets reached record highs, increasing 12% and 18% year-over-year, respectively, driven by market appreciation and strong net asset inflows. Treasury deposits grew 35% over the prior year, reflecting the effectiveness of our venture and fund banking deposit initiatives, essentially offsetting declines in client money market and insured product balances. Bank loans rose 1% since September, supported by higher...

– Alpha DaRT pancreatic cancer patient treatments underway in U.S. multi-center pilot study – – Newly received radioactive material license for New Hampshire facility positions the Company for continued advancement towards commercial readiness – – Multiple meaningful milestones targeted in the coming months, including completion of patient recruitment in the U.S. pivotal ReSTART trial – – Cash, cash equivalents & deposits balance of $75.9 million provides runway for continued clinical advancement and commercial preparation – JERUSALEM, Nov. 20, 2025 (GLOBE NEWSWIRE) — Alpha Tau Medical Ltd. (“Alpha Tau”, or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, reported third quarter 2025 financial results...

Maroussi, Greece, November 20, 2025 – Pyxis Tankers Inc. (Nasdaq Cap Mkts: PXS), (the “Company”, “we”, “our”, “us” or “Pyxis Tankers”), an international diversified shipping company, today announced unaudited results for the three and nine month periods ended September 30, 2025. For the three months ended September 30, 2025, our revenues, net, were $9.7 million. For the same period, our time charter equivalent (“TCE”) revenues were $8.9 million, a decrease of $2.7 million, or 23.5%, over the comparable period in 2024. Our net income attributable to common shareholders for the third quarter ended September 30, 2025 was $1.2 million, compared to net income of $3.6 million for the same period in 2024. For the third quarter of 2025, the net income per common share was $0.11 basic and diluted compared to a net income per common share of $0.34...

Helstu atriði úr fjárhagsuppgjöri 3F 2025Vörusala var 111 m€ á fjórðungnum samanborið við 110 m€ á þriðja fjórðungi 2024 Hagnaður var 29 m€ á fjórðungnum samanborið við 19 m€ á þriðja fjórðungi 2024 EBITDA var 42 m€ og EBITDA hlutfall 37,3% Eignir hafa lækkað um 13 m€ frá áramótum og voru 983 m€ í lok tímabilsins Eigið fé þann 30. september 2025 var 505 m€ og eignfjárhlutfall 51,4%Guðmundur Kristjánsson, forstjóri: „Afkoma þriðja fjórðungs er góð og eru það tveir þættir sem skipta mestu máli. Veiðar og vinnsla á makríl gengu vel og verð á sjávarafurðum er hátt um þessar mundir. Þegar við horfum til seinustu 12 mánaða er ávöxtun eigin fjár 12%. Í september var tilkynnt um kauptilboð félagsins í allt hlutafé Lýsis hf. Með kaupunum sér Brim mikil samlegðar- og sóknarfæri bæði tengt hráefnaöflun Lýsis og fyrir Brim til að ná lengra í...